The Supreme Court of Canada is planning to announce judgments in five intellectual property related leave applications on Thursday, May 5, 2011. The leave applications relate to fair dealing, s.8 damages under the PM(NOC) regulations, the Saccharin doctrine and insufficiency.

The cases are:

• Access Copyright (SCC #33888) relating to copyright fair dealing in educational situations.
• Pharmascience v. Aventis Pharma (ramipril) (SCC #33831) and Apotex v. Hoffmann Laroche (naproxen) (SCC #33832) both relating to s.8 damages under the PM(NOC) regulations.
• Apotex v. Eli Lilly (cefaclor) (SCC #33946) relating to the Saccharin doctrine.
• Teva v. Pfizer (sildenafil) (SCC #33951) relating to the insufficiency invalidity allegation.

More information about these and other intellectual property proceedings at the Supreme Court are available on the Supreme Court litigation page.